Hundreds of French Citizens Suffer Cardiac Events After Bivalent Boosters

The adverse events caused by the mRNA-induced Wuhan Spike protein of COVID-19 vaccines can be attributed to the product within a 30-day regulatory window post-injection, according to someone who has served on or chaired two dozen data safety monitoring boards for randomized trials of novel experimental drugs or devices.

Recently, Jabagi et al. reported in the New England Journal of Medicine that cardiovascular events occurred after the administration of mRNA BA4/BA5 bivalent boosters in individuals who were aged 50 and over and who had received a booster dose between Oct. 6 and Nov. 9, 2022. The 335 individuals experienced a combination of ischemic/hemorrhagic stroke, myocardial infarction, or pulmonary embolism.

However, the authors divided the cases by the entire number vaccinated, which is invalid since there is incomplete capture of events, and they did not compare the rates to a placebo or control group.

These findings suggest that many serious and potentially fatal safety events are occurring within 21 days after bivalent mRNA boosters. These events should be regarded as severe and directly linked to COVID-19 vaccination. If individuals have not been vaccinated, they would most likely be free from these complications today.

If you enjoy and find “Courageous Discourse” helpful for your endeavors, please consider subscribing as a paying or founder member to support their efforts in assisting you in engaging in these discussions with family, friends, and extended networks.

Reposted from Peter A. McCullough’s Substack

◇ Reference:

Jabagi MJ, Bertrand M, Botton J, Le Vu S, Weill A, Dray-Spira R, Zureik M. Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster. N Engl J Med. 2023 Mar 29. doi: 10.1056/NEJMc2302134. Epub ahead of print. PMID: 36988584.

The opinions expressed in this article are those of the author and do not necessarily reflect the views of The Epoch Times. Epoch Health welcomes professional discussion and friendly debate. To submit an opinion piece, please follow these guidelines and submit through our form here.